MGI Pharma just secured a $75mil credit line http://investors.mgipharma.com/phoenix.zhtml?c=73842&p=irol-sec Anyone think this will have an effect on SUPG (Dacogen or full buyout)? I don't follow MGI much but am pretty sure they will pay way more in royalties over then next twenty years for Dacogen so why not buy SUPG soon.
Supg would require about 500M to acquire it. Maybe a cash and stock offer? I think were still a year away from this possibility. Dacogen would have to validate the 200-300M U.S. sales revenue to get Mogn that excited to buy SUPG. Just my thoughts.